ATAI Life Sciences NV Strategic Asset Allocation Index
ATAI Life Sciences NV strategic asset allocation index. ATAI Life Sciences NV (9VC) has a Strategic Asset Allocation Index of 55.3% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €88.36 Million) total €88.36 Million, measured against net assets of €159.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 9VC net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ATAI Life Sciences NV (2019–2024)
Strategic asset allocation index of ATAI Life Sciences NV from 2019 to 2024. This chart shows how ATAI Life Sciences NV's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at 55.3%, representing strategic assets of €88.36 Million against net assets of €159.91 Million EUR. Check tangible net worth ratio of ATAI Life Sciences NV to evaluate the tangible quality of the company's equity base.
ATAI Life Sciences NV Strategic Asset Allocation Index by Year (2019–2024)
ATAI Life Sciences NV strategic asset allocation index by year from 2019 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for ATAI Life Sciences NV from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ATAI Life Sciences NV (9VC) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.9% | €70.97 Million | €- | €70.97 Million | €116.55 Million | ▲ +23.4 pp |
| 2023 | 37.5% | €91.66 Million | €- | €91.66 Million | €244.32 Million | ▲ +35.0 pp |
| 2022 | 2.5% | €6.75 Million | €- | €6.75 Million | €265.77 Million | ▼ -4.7 pp |
| 2021 | 7.2% | €27.76 Million | €- | €27.76 Million | €385.96 Million | ▼ -1.2 pp |
| 2020 | 8.4% | €8.04 Million | €- | €8.04 Million | €95.37 Million | ▼ -30.0 pp |
| 2019 | 38.5% | €22.95 Million | €- | €22.95 Million | €59.64 Million | — |